# Who may be a fit, and what to ask about cost *Who May Be a Fit — Regenerative Medicine Chandler* > Regenerative medicine Chandler guidance on who may be a fit, when soreness needs a visit, and what to ask about the full cost. A knee that once eased overnight may ache again at the breakfast table. Notice that change before you spend money on more care. ## What to try before paying for more care Gentle exercise helps the muscles steady a sore joint. It may make movement easier even when the wear remains. Use movements already taught by your doctor or therapist. If you haven't had that help, ask which exercises suit your joint. Give the painful task a rest while keeping other activity easy. Long quiet spells can leave the joint stiffer. Tell the doctor what earlier care helped or made things worse. No single treatment is right for every cause of soreness. ## When to arrange an exam or urgent care Make an appointment when repeated aches begin blocking normal tasks. Trouble sleeping, walking, or dressing shows how much the joint affects you. A doctor will look for swelling, lost motion, weakness, and a tender area. Those findings help the doctor tell whether soreness starts in the joint, along a tendon, or within nearby tissue needing different care before any paid treatment can be considered. A hot, red, very swollen joint with fever may be infected. Seek urgent medical help instead of waiting for a planned treatment visit. New weakness, numbness, or a leg that won't hold you also needs prompt care. Don't force a hurt joint that has locked in place. ## What to ask if the soreness keeps limiting you QC Kinetix can discuss regenerative treatment, a non-surgical choice that may use material from your blood. The doctor will check your joint, health, past care, and goal before saying whether it may fit. A better fit may have steady soreness despite exercise or therapy and want less pain. It isn't a fit for someone expecting worn tissue to grow back. The doctor also needs to know about blood-thinning medicine, bleeding trouble, or infection. Those facts can change whether treatment is safe now. Insurance may not pay, so ask for the full price in writing. Check whether every planned visit and later follow-up is included. Knee or hip surgery alternatives may appeal when recovery worries you. They can't promise that an operation will never be needed. ## Sources 1. The Cochrane review of exercise for knee osteoarthritis found high-quality evidence that land-based therapeutic exercise provides short-term benefit in pain and physical function, sustained for at least 2-6 months after the programme ends, with mild transient soreness the only reported adverse effect across 45 trials. It is the best-evidenced treatment for this condition and it costs nothing per injection. Fransen M, et al. — [Exercise for osteoarthritis of the knee.](https://pubmed.ncbi.nlm.nih.gov/25569281/). *The Cochrane database of systematic reviews*, 2015. DOI: 10.1002/14651858.CD004376.pub3. 2. The AAOS third-edition clinical practice guideline for non-arthroplasty management of knee osteoarthritis is the orthopedic profession's own GRADE-style appraisal of the same options a regenerative clinic sells; it is the benchmark against which any 'regenerative' claim on this topic should be read, and it rates the strongest support for exercise, weight loss and self-management rather than for injectables. Brophy RH, et al. — [AAOS Clinical Practice Guideline Summary: Management of Osteoarthritis of the Knee (Nonarthroplasty), Third Edition.](https://pubmed.ncbi.nlm.nih.gov/35383651/). *The Journal of the American Academy of Orthopaedic Surgeons*, 2022. DOI: 10.5435/JAAOS-D-21-01233. 3. A cross-sectional study contacted 273 of 317 US centres offering direct-to-consumer stem-cell therapy, posing as a 57-year-old man with knee osteoarthritis. The mean advertised price of a unilateral same-day stem-cell knee injection was $5,156 (SD $2,446), and centres claimed a mean clinical efficacy of 82% (SD 9.6%) - a figure with no support in the published evidence. The gap between the quoted number and the trial data is the single most useful thing a patient can be told before a consultation. Piuzzi NS, et al. — [The Stem-Cell Market for the Treatment of Knee Osteoarthritis: A Patient Perspective.](https://pubmed.ncbi.nlm.nih.gov/28738432/). *The journal of knee surgery*, 2018. DOI: 10.1055/s-0037-1604443. 4. Medicare's National Coverage Determination covers autologous platelet-rich plasma ONLY for chronic non-healing diabetic, pressure or venous WOUNDS, and only under Coverage with Evidence Development inside an approved clinical research study. There is no Medicare coverage pathway for PRP as a treatment for osteoarthritis or any other joint indication, which is why these injections are quoted as cash prices. Centers for Medicare & Medicaid Services — [Autologous Platelet-rich Plasma (Coverage with Evidence Development)](https://www.cms.gov/medicare/coverage/evidence/plasma). *CMS.gov*, 2012. 5. FDA states plainly that no stem cell, exosome, stromal vascular fraction, umbilical cord blood, Wharton's jelly or amniotic-fluid product has been approved for the treatment of ANY orthopedic condition - it names osteoarthritis, tendonitis, disc disease, tennis elbow, back pain, hip pain, knee pain, neck pain and shoulder pain individually. The only FDA-approved stem cell products in the United States are cord-blood-derived blood-forming stem cells for disorders of the hematopoietic system, and there are currently no FDA-approved exosome products. US Food and Drug Administration, Center for Biologics Evaluation and Research — [Consumer Alert on Regenerative Medicine Products Including Stem Cells and Exosomes](https://www.fda.gov/vaccines-blood-biologics/consumers-biologics/consumer-alert-regenerative-medicine-products-including-stem-cells-and-exosomes). *FDA*, 2020. 6. A 2026 systematic review and meta-analysis of 28 randomized trials of intra-articular mesenchymal stem cell-based therapies in knee OA found significant improvements in several pain and function measures (delta-VAS MD -1.67; KOOS pain MD 15.37) but NO significant difference in WOMAC, KOOS quality of life or the Lequesne index, and MRI-based WORMS scores were non-significant - indicating no consistent structural benefit. Its own conclusion: these therapies serve a primarily SYMPTOM-modifying rather than STRUCTURE-modifying role, with higher frequencies of local reactions to weigh against the symptomatic benefit. Awad G, et al. — [Efficacy and safety of intra-articular mesenchymal stem cell-based therapies in knee osteoarthritis: A systematic review and meta-analysis of randomized controlled trials.](https://pubmed.ncbi.nlm.nih.gov/41863718/). *Clinical rheumatology*, 2026. DOI: 10.1007/s10067-026-08042-w. ## What to do when the joint stays sore QC Kinetix offers a consultation at no charge at its Chandler clinic on South Dobson Road. A medical provider will examine your joint, review earlier care, and discuss regenerative treatment options that may fit. Take your medicines and old reports, then ask about likely relief, recovery, limits, and full cost. You can go home and decide after you have those answers. Schedule a free consultation: --- Clear help when a joint stays sore. Plain help for joint soreness in Chandler, from easy home measures to warning signs and non-surgical care. Plain facts about aching joints, simple measures, danger signs, and non-surgical choices in Chandler. This site is operated by the owners of the QC Kinetix clinics in the Phoenix area, including the Chandler location at 1100 S. Dobson Rd., Suite 210. It is a commercial publication and carries no reviews, ratings or patient stories. © 2026 The Word and the Evidence · Chandler, Arizona. Educational content only, not medical advice about your particular joint.